Physician profile
Olivia Grabmayer
NPI 1487120424
$488.98
in general payments reported to CMS, 2019-2025
11 companies · $81.68 in 2025
The $81.68 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.47 · 2022: $174 · 2023: $57.90 · 2024: $120 · 2025: $81.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $259.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $206.10 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $74.93 | 2022-2024 | Farxiga |
| Abbott Laboratories | $46.89 | 2024 | Esprit, Diamondback Peripheral |
| Amgen INC. | $38.60 | 2022-2024 | Repatha |
| Ethicon US, LLC | $19.67 | 2021 | |
| Getinge USA Sales, LLC | $19.24 | 2021 | |
| Medtronic, INC. | $19.23 | 2023 | Corevalve Evolut R |
| Astellas Pharma US INC | $17.23 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.94 | 2024 | Xarelto |
| Bard Peripheral Vascular, INC. | $16.56 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.59 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Grabmayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.